Department of Health and Human Services April 21, 2005 – Federal Register Recent Federal Regulation Documents

National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health
Document Number: 05-8088
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Office of Loan Repayment; Submission for OMB Review; Comment Request; National Institutes of Health Loan Repayment Programs
Document Number: 05-8003
Type: Notice
Date: 2005-04-21
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of Loan Repayment, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on December 10, 2004, and allowed 60 days for public comment. No responses to the notice were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. The programs have existing data collections with an OMB control number (OMB No. 0925- 0361, expiration date 12/31/2004). An extension has been granted until March 2005 due to an administrative delay caused by a change in office responsible for the LRPs.
National Institute of Environmental Health Sciences; Notice of Closed Meeting
Document Number: 05-8002
Type: Notice
Date: 2005-04-21
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Environmental Health Sciences; Notice of Closed Meeting
Document Number: 05-8001
Type: Notice
Date: 2005-04-21
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Document Number: 05-8000
Type: Notice
Date: 2005-04-21
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Injury Prevention and Control Initial Review Group
Document Number: 05-7995
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Healthcare Infection Control Practices Advisory Committee: Notice of Charter Renewal
Document Number: 05-7993
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Breast and Cervical Cancer Early Detection and Control Advisory Committee
Document Number: 05-7992
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting
Document Number: 05-7991
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
National Center for Injury Prevention and Control Initial Review Group
Document Number: 05-7989
Type: Notice
Date: 2005-04-21
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Administration on Children, Youth and Families 2005 Head Start Tribally Controlled Land Grant College and University Partnerships; Notice of Correction for the FY 05 Head Start Tribally Controlled Land Grant College and University Partnerships Program Announcement, HHS-2005-ACF-ACYF-YT-0012, CFDA# 93.600
Document Number: 05-7949
Type: Notice
Date: 2005-04-21
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
This notice is to inform interested parties of corrections to the Head Start Tribally Controlled Land Grant College and University Partnerships Program Announcement that was published on Wednesday, April 13, 2005. The following corrections should be noted: (1) Under Priority Areas I, Section VII. Agency Contacts, Program Office Contact, please delete the following name, address, phone number, and e-mail address: Katherine Gray, U.S. Department of Health and Human Services, Administration for Children and Families, ACYF Head Start Bureau, 330 C Street, SW., Switzer Room 2211, Washington, DC 20447. Phone: 312-353-2260. E-mail: kgray@acf.hhs.gov. Please replace the deleted name, address, phone number, and e-mail address with the following: Rosalind Dailey, U.S. Department of Health and Human Services, Administration for Children and Families, ACYF Head Start Bureau, 330 C Street, SW., Switzer Room 2211, Washington, DC 20447. Phone: 202-205-8653. E-mail: rdailey@acf.hhs.gov. All information in this notice of correction is accurate and replaces information specified in the April 13 notice. Applications are still due by the deadline date that was published in the April 13 notice (May 13 for Letters of Intent or Preapplications and June 13 for Applications).
Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
Document Number: 05-7948
Type: Notice
Date: 2005-04-21
Agency: Food and Drug Administration, Department of Health and Human Services
Guidance for Industry and Food and Drug Administration Staff on Application User Fees for Combination Products; Availability
Document Number: 05-7947
Type: Notice
Date: 2005-04-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry and FDA staff entitled ``Application User Fees for Combination Products.'' This document provides guidance to industry and FDA staff on marketing application user fees for combination products. The guidance also describes how the ``barrier to innovation'' waiver provision under the prescription drug user fee provisions of the Federal Food, Drug, and Cosmetic Act (the act) may be applied to innovative combination products in the infrequent situation where FDA requires the submission of two marketing applications.
Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Content of Labeling; Availability
Document Number: 05-7946
Type: Notice
Date: 2005-04-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Providing Regulatory Submissions in Electronic FormatContent of Labeling.'' This guidance is one in a series of guidance documents on providing regulatory submissions to FDA in electronic format. FDA's regulations require that the content of labeling for marketing applications be submitted in electronic format in a form that FDA can process, review, and archive. The guidance provides information on submitting the content of labeling in electronic format for review with new drug applications (NDAs), abbreviated new drug applications (ANDAs), and biological license applications (BLAs) for biological products that meet the definition of drug in the Federal Food, Drug, and Cosmetic Act.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.